RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Novel dual PPARalpha/gamma agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects.

Novel dual PPARalpha/gamma agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects.

Add to Collection
2022 Nov 15 Others Fist_Author_Year_PM

Full Author : ['Guru, Bhavimani', 'Tamrakar, Akhilesh K', 'Manjula, S N', 'Prashantha Kumar, B R']
Journal Title : European journal of pharmacology
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

Insulin resistance is a feature of type 2 diabetes mellitus (T2D), and is strongly interconnected with non-alcoholic fatty liver disease (NAFLD). Peroxisome-proliferator activated receptor gamma (PPARgamma) and peroxisome-proliferator activated receptor a.....

Keywords : ["novel dual pparalphagamma agonist protect", "improve insulin sensitivity", "avoid side effect", "liver steatosis"]